Login / Signup

Positive Allosteric Modulation of CB1 and CB2 Cannabinoid Receptors Enhances the Neuroprotective Activity of a Dual CB1R/CB2R Orthosteric Agonist.

Beatrice PoliniChiara CervettoSara CarpiSimone PelassaFrancesca GadoRebecca FerrisiSimone BertiniPaola NieriManuela MarcoliClementina Manera
Published in: Life (Basel, Switzerland) (2020)
Preclinical studies highlighted that compounds targeting cannabinoid receptors could be useful for developing novel therapies against neurodegenerative disorders. However, the chronic use of orthosteric agonists alone has several disadvantages, limiting their usefulness as clinically relevant drugs. Positive allosteric modulators might represent a promising approach to achieve the potential therapeutic benefits of orthosteric agonists of cannabinoid receptors through increasing their activity and limiting their adverse effects. The aim of the present study was to show the effects of positive allosteric ligands of cannabinoid receptors on the activity of a potent dual orthosteric agonist for neuroinflammation and excitotoxic damage by excessive glutamate release. The results indicate that the combination of an orthosteric agonist with positive allosteric modulators could represent a promising therapeutic approach to the treatment of neurodegenerative disorders.
Keyphrases
  • small molecule
  • stem cells
  • oxidative stress
  • cerebral ischemia
  • bone marrow
  • cancer therapy
  • cell therapy
  • mesenchymal stem cells
  • drug induced
  • case control
  • structural basis